# Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy

> **NCT07076914** · PHASE2 · NOT_YET_RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 58 (estimated)

## Conditions studied

- Primary Lung Cancer
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer

## Interventions

- **DRUG:** Experimental (Health Canada Approved Proton Pump Inhibitors)

## Key facts

- **NCT ID:** NCT07076914
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-02
- **Primary completion:** 2028-01-02
- **Final completion:** 2032-10-02
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07076914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07076914, "Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07076914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*